First Time in Human Study

The Safety, Tolerability, and Pharmacokinetics Study of HEC113995 PA•H2O Tablets in Healthy Subjects

NCT04591301 ·Status: COMPLETED ·Phase: PHASE1

Relative Bioavailability and Food Effect Study for GSK163090 in Healthy Male and Female Volunteers

NCT00536679 ·Status: COMPLETED ·Phase: PHASE1

Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder

NCT00135421 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety, Tolerability, PK and Efficacy of Single Doses of NV-5138 in Healthy Volunteers and Subjects With Treatment-Resistant Depression

NCT03606395 ·Status: COMPLETED ·Phase: PHASE1

ELE-101 Safety & Tolerability Study in Healthy Participants and Patients With Depression

NCT05434156 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Biological Aspects of Depression and Antidepressant Drugs

NCT00018733 ·Status: COMPLETED ·Phase: NA

the Safety, Tolerability, and Pharmacokinetics Study of HEC113995

NCT04623814 ·Status: COMPLETED ·Phase: PHASE1

AZD6765 for Treatment Resistant Depression

NCT00491686 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of NBI-1070770 in Adults With Major Depressive Disorder

NCT06267846 ·Status: COMPLETED ·Phase: PHASE2

This is a Study to Determine the Antidepressant Effects of AZD6765

NCT00986479 ·Status: COMPLETED ·Phase: PHASE2

The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

NCT05973851 ·Status: RECRUITING ·Phase: PHASE3

Pharmacokinetics - Pharmacodynamic Study of HT-2157 in Healthy Subjects and in Patients With Major Depressive Disorder

NCT01413932 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Test Different Doses of BI 1569912 in People With Depression

NCT06558344 ·Status: COMPLETED ·Phase: PHASE2

A Study to Test How Well Different Doses of BI 1569912 Are Tolerated and How Well They Work in People With Depression Who Take Anti-depressive Medication

NCT04937829 ·Status: COMPLETED ·Phase: PHASE1

A Study To Evaluate The Safety, Tolerability And Pharmacokinetics of HS-10345 In Treatment-Resistant Depression

NCT05196971 ·Status: COMPLETED ·Phase: PHASE1

Study of Antidepressant Efficacy of a Selective, High Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder (AMDD)

NCT00759395 ·Status: COMPLETED ·Phase: PHASE2

Safety, Pharmacokinetics and Pharmacodynamics Study of BMS-866949 in Healthy Subjects

NCT00949767 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics, Effect of Food, Safety and Tolerability of a New Tablet Formulation of GSK1144814 in Healthy Subjects

NCT01090440 ·Status: COMPLETED ·Phase: PHASE1

"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"

NCT06564818 ·Status: RECRUITING ·Phase: PHASE3

Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder

NCT06058013 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder

NCT06058039 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005

NCT02271412 ·Status: COMPLETED ·Phase: PHASE1

GSK372475 Bioequivalence Study

NCT00488098 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive Disorder

NCT02741791 ·Status: COMPLETED ·Phase: PHASE3

Safety and Pharmacodynamic Study of ABT-436 in Major Depressive Disorder

NCT01380704 ·Status: COMPLETED ·Phase: PHASE1